These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 28748534)
1. miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma. Satterfield L; Shuck R; Kurenbekova L; Allen-Rhoades W; Edwards D; Huang S; Rajapakshe K; Coarfa C; Donehower LA; Yustein JT Int J Cancer; 2017 Nov; 141(10):2062-2075. PubMed ID: 28748534 [TBL] [Abstract][Full Text] [Related]
2. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma. Garcia-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Herrero-Martín D; Huertas-Martinez J; Lagares-Tena L; Alba-Pavón P; Hontecillas-Prieto L; Mora J; de Álava E; Rello-Varona S; Giangrande PH; Tirado OM Int J Cancer; 2018 Sep; 143(5):1188-1201. PubMed ID: 29582409 [TBL] [Abstract][Full Text] [Related]
3. Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis. Luo W; Xu C; Ayello J; Dela Cruz F; Rosenblum JM; Lessnick SL; Cairo MS Oncogene; 2018 Feb; 37(6):798-809. PubMed ID: 29059150 [TBL] [Abstract][Full Text] [Related]
4. MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer. Chen R; Zhang L Anticancer Drugs; 2019 Jul; 30(6):579-587. PubMed ID: 30724771 [TBL] [Abstract][Full Text] [Related]
5. miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1. Geng A; Luo L; Ren F; Zhang L; Zhou H; Gao X BMC Cancer; 2021 Jul; 21(1):843. PubMed ID: 34289832 [TBL] [Abstract][Full Text] [Related]
6. miR-124 represses the mesenchymal features and suppresses metastasis in Ewing sarcoma. Li Y; Shao G; Zhang M; Zhu F; Zhao B; He C; Zhang Z Oncotarget; 2017 Feb; 8(6):10274-10286. PubMed ID: 28055964 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells. Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737 [TBL] [Abstract][Full Text] [Related]
8. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis. Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5. Hu H; Zhang Q; Chen W; Wu T; Liu S; Li X; Luo B; Zhang T; Yan G; Lu H; Lu Z Carcinogenesis; 2020 Jun; 41(4):502-514. PubMed ID: 31233116 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2. Hirono T; Jingushi K; Nagata T; Sato M; Minami K; Aoki M; Takeda AH; Umehara T; Egawa H; Nakatsuji Y; Kitae K; Ueda Y; Hase H; Yamamoto M; Shinsato Y; Kawahara K; Furukawa T; Tsujikawa K Sci Rep; 2019 May; 9(1):6956. PubMed ID: 31061410 [TBL] [Abstract][Full Text] [Related]
12. Exosomal miR-130b-3p suppresses metastasis of non-small cell lung cancer cells by targeting DEPDC1 via TGF-β signaling pathway. Lv M; Li X; Zheng C; Tian W; Yang H; Yin Z; Zhou B Int J Biol Macromol; 2024 Aug; 275(Pt 1):133594. PubMed ID: 38960258 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer. Zhang D; Zhao L; Shen Q; Lv Q; Jin M; Ma H; Nie X; Zheng X; Huang S; Zhou P; Wu G; Zhang T Int J Cancer; 2017 May; 140(10):2298-2309. PubMed ID: 28213952 [TBL] [Abstract][Full Text] [Related]
14. Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma. Krook MA; Nicholls LA; Scannell CA; Chugh R; Thomas DG; Lawlor ER Mol Cancer Res; 2014 Jun; 12(6):953-64. PubMed ID: 24651452 [TBL] [Abstract][Full Text] [Related]
15. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway. Li J; You T; Jing J Cell Prolif; 2014 Apr; 47(2):152-60. PubMed ID: 24517182 [TBL] [Abstract][Full Text] [Related]
16. The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis. Sechler M; Parrish JK; Birks DK; Jedlicka P Oncogene; 2017 Jul; 36(29):4150-4160. PubMed ID: 28319067 [TBL] [Abstract][Full Text] [Related]
17. p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma. Qasim SL; Sierra L; Shuck R; Kurenbekova L; Patel TD; Rajapakshe K; Wulff J; Nakahata K; Kim HR; Landesman Y; Unger TJ; Coarfa C; Yustein JT Oncogene; 2021 Feb; 40(6):1176-1190. PubMed ID: 33414491 [TBL] [Abstract][Full Text] [Related]
19. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells. Huang Y; Luo F IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145 [TBL] [Abstract][Full Text] [Related]
20. miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer. Liu X; Bi L; Wang Q; Wen M; Li C; Ren Y; Jiao Q; Mao JH; Wang C; Wei G; Wang Y Oncogene; 2018 Jun; 37(25):3426-3439. PubMed ID: 29555976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]